StonvexLoading…
StonvexStonvexStonvexCore line items from MIR's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Q1 2026 2026-03-31 | Annual 2025 2025-12-31 | Q3 2025 2025-09-30 | Q2 2025 2025-06-30 |
|---|---|---|---|---|
Revenue | $257.60M | $925.40M | $648.00M | $424.90M |
Operating Income | $3.70M | $51.50M | $26.00M | $18.60M |
Net Income | $-3.40M | $28.80M | $11.50M | $8.60M |
EPS (Diluted) | $-0.01 | $0.11 | $0.04 | $0.04 |
Total Assets | $3.54B | $3.59B | $3.50B | $2.74B |
Total Liabilities | $1.65B | $1.67B | $1.60B | $1.22B |
Cash & Equivalents | $397.90M | $412.30M | $933.20M | $262.60M |
Free Cash Flow OCF − CapEx | $9.40M | $106.90M | $43.70M | $30.70M |
Shares Outstanding | 244.66M | 261.15M | 18.75M | 18.75M |